tiprankstipranks
Trending News
More News >
Palisade Bio (PALI)
NASDAQ:PALI
US Market

Palisade Bio (PALI) Financial Statements

Compare
530 Followers

Palisade Bio Financial Overview

Palisade Bio's market cap is currently $2.96M. The company's EPS TTM is $-0.47; its P/E ratio is ―; Palisade Bio is scheduled to report earnings on May 9, 2025, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 250.00K$ 0.00$ 0.00$ 13.52K
Gross Profit$ 0.00$ 250.00K$ -167.00K$ -168.00K$ -132.00K
Operating Income$ -14.86M$ -13.07M$ -15.72M$ -11.74M$ -9.30M
EBITDA$ -14.86M$ -12.28M$ -15.15M$ -24.05M$ -9.94M
Net Income$ -14.44M$ -12.30M$ -14.26M$ -26.62M$ -10.32M
Balance Sheet
Cash & Short-Term Investments$ 9.82M$ 12.43M$ 12.38M$ 10.49M$ 713.00K
Total Assets$ 10.88M$ 14.05M$ 15.76M$ 12.51M$ 3.02M
Total Debt$ 169.00K$ 369.00K$ 404.00K$ 199.00K$ 1.42M
Net Debt$ -9.65M$ -12.06M$ -11.98M$ -10.30M$ 708.00K
Total Liabilities$ 3.39M$ 2.74M$ 3.28M$ 5.15M$ 19.62M
Stockholders' Equity$ 7.49M$ 11.31M$ 12.48M$ 7.37M$ -16.60M
Cash Flow
Free Cash Flow$ -12.19M$ -11.14M$ -13.37M$ -14.77M$ -4.77M
Operating Cash Flow$ -12.19M$ -11.13M$ -13.36M$ -14.77M$ -4.77M
Investing Cash Flow$ 0.00$ -4.00K$ -10.00K$ -54.00K$ -6.00K
Financing Cash Flow$ 9.58M$ 11.19M$ 15.26M$ 24.61M$ 1.89M
Currency in USD

Palisade Bio Earnings and Revenue History

Palisade Bio Debt to Assets

Palisade Bio Cash Flow

Palisade Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis